Rare Diseases

Quoin Pharmaceuticals Shares Jump on $104.5 Million Private Placement With $16.8 Million Upfront

The rare-disease developer plans to use the premium-priced funding, set to close around Oct. 14, to advance QRX003 for Netherton Syndrome.